Core Laboratories (NYSE:CLB) Downgraded by Wall Street Zen to Sell

Key Points

• Core Laboratories was downgraded by Wall Street Zen from hold to sell, while Weiss Ratings also lowered its view on the stock.
• The shares fell 2.3% to $13.15, trading well below their 50-day and 200-day moving averages of $16.40 and $16.80, respectively.
• Despite the downgrade, the company recently met earnings estimates with Q1 EPS of $0.06, though revenue slightly missed expectations and was down 1.4% year over year.

Core Laboratories (NYSE:CLB - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued on Saturday.

Separately, Weiss Ratings lowered shares of Core Laboratories from a "hold (c)" rating to a "hold (c-)" rating in a research note on Monday. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Core Laboratories currently has an average rating of "Hold" and a consensus price target of $12.50.

Core Laboratories Stock Down 2.3%

Core Laboratories stock opened at $13.15 on Friday. The company's 50 day simple moving average is $16.40 and its 200 day simple moving average is $16.80. Core Laboratories has a fifty-two week low of $9.72 and a fifty-two week high of $20.36. The firm has a market capitalization of $605.98 million, a price-to-earnings ratio of 20.22, a PEG ratio of 2.53 and a beta of 0.99. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.05 and a quick ratio of 1.50.

Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, hitting the consensus estimate of $0.06. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The business had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. During the same quarter last year, the firm earned $0.14 EPS. Core Laboratories's quarterly revenue was down 1.4% compared to the same quarter last year. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. As a group, sell-side analysts anticipate that Core Laboratories will post 0.57 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of CLB. CWA Asset Management Group LLC bought a new position in Core Laboratories in the fourth quarter valued at approximately $9,978,000. Goldman Sachs Group Inc. lifted its stake in Core Laboratories by 185.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company's stock valued at $13,549,000 after buying an additional 548,657 shares in the last quarter. Disciplined Growth Investors Inc. MN lifted its stake in Core Laboratories by 9.7% in the third quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company's stock valued at $73,787,000 after buying an additional 528,976 shares in the last quarter. MAC Alpha Capital Management LP bought a new position in Core Laboratories in the fourth quarter valued at approximately $5,016,000. Finally, Heartland Advisors Inc. bought a new position in Core Laboratories in the first quarter valued at approximately $2,518,000. Institutional investors own 97.81% of the company's stock.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company's portfolio spans two primary service lines: reservoir description and production enhancement.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.